ERBB2 and breast cancer: This study aims to develop and validate a Vision Transformer (ViT) model based on dynamic contrast‐enhanced MRI (DCE‐MRI) to classify HER2‐zero, ‐low, and ‐positive breast cancer patients and to explore its interpretability.